About

At PlexoBio, we make the inaccessible accessible by using proprietary technology to connect researchers with high-quality, ethically sourced preclinical models and human biospecimens, accelerating biomarker-based drug discovery and the development of life-changing treatments.

Problem

In the fields of cancer, fibrosis, and cardiovascular research, accessing high-quality, ethically sourced preclinical models and human biospecimens is often hindered by fragmented and inefficient supply chains. The process of identifying reliable suppliers is complex and time-consuming, limiting the ability of researchers to leverage accurate data for drug discovery and increasing the risk of trial failures.

Solution

PlexoBio uses proprietary technology to streamline global access to top suppliers of preclinical models and human biospecimens. Our digital platform provides researchers with seamless, data-driven access to high-quality, ethically sourced resources, accelerating drug discovery and advancing innovative treatments.

Founders Story

PlexoBio was founded by Dr. Indrabahadur Singh – an Emmy Noether DFG Grant Award Recipient – and Dr. Anshu Singh – an EXIST Women Grant Award Recipient – both pioneers in preclinical research with a strong focus on oncology and fibrosis. Throughout their careers, they faced a common challenge: the difficulty of accessing high-quality, ethically sourced preclinical models and human biospecimens. This barrier significantly impacted their own translational research, slowing progress and hindering the development of critical insights in cancer and fibrosis research.

Frustrated by the inefficiencies and complexities of sourcing reliable models, they decided to take action. Drawing from their years of experience using advanced preclinical models and human biospecimens to drive cancer research, they founded PlexoBio with a clear mission: to make these vital resources accessible to researchers and innovators. Driven by a passion for empowering the next generation of biopharma leaders, Dr. Singh and Dr. Singh are committed to providing the most accurate, effective preclinical models and biospecimens, accelerating drug discovery and advancing precision therapies.

Indrabahadur Singh

Dr. Indrabahadur Singh

Founder

With over 15+ years of precision R&D expertise in pre-clinical research…

Anshu Singh

Dr. Anshu Singh

Founder

With over 10+ years of experience in pre-clinical…

Empowering Research Through Access to Critical Resources

At PlexoBio, we understand the challenges of accessing high-quality preclinical models and biospecimens, as our founders experienced firsthand. That’s why we’re committed to providing the resources that accelerate drug discovery and drive innovation in biopharma.

What Our Clients Say

With the help of the PlexoBio team, we identified and implemented the perfect preclinical cancer model, boosting the accuracy of our drug development process.

Client 1

Senior Oncology Research Scientist

Thanks to PlexoBio’s expertise, we gained access to high-quality human lung fibrosis biospecimens, transforming our preclinical research and enhancing clinical relevance.

Client 2

Pre-Clinical Researcher